Literature DB >> 8434356

Segregation of eosinophil proteins in alveolar macrophage compartments in chronic eosinophilic pneumonia.

A Janin1, G Torpier, P Courtin, M Capron, L Prin, A B Tonnel, P Y Hatron, B Gosselin.   

Abstract

BACKGROUND: The objective was to characterise the process and consequences of eosinophil activation and lysis in patients with chronic eosinophilic pneumonia and to compare them with those in patients with eosinophil pulmonary infiltrates from other causes.
METHODS: Cells from bronchoalveolar lavage fluid of four patients with chronic eosinophilic pneumonia and four patients with eosinophilic infiltrates associated with Sjögren's syndrome, drug hypersensitivity pneumonia, postradiotherapy fibrosis, and pulmonary disease associated with graft versus host disease were studied ultrastructurally and with immunogold labelled antibodies directed against eosinophil proteins: major basic protein, eosinophil cationic protein, and Charcot-Leyden crystal protein. The concentration of eosinophil cationic protein was also measured in bronchoalveolar fluid.
RESULTS: In the four patients with chronic eosinophilic pneumonia, ultrastructural studies demonstrated numerous lysed eosinophils. Further, three released eosinophil proteins were detected in distinct cytoplasmic structures in alveolar macrophages. These features were not found in the four patients with eosinophilic pulmonary infiltrates from other causes.
CONCLUSION: Eosinophils in chronic eosinophilic pneumonia show signs of activation with release of eosinophil proteins. The appearance of three of these eosinophil proteins in different macrophage compartments suggests that macrophage uptake, with or without intracellular transport of released eosinophil proteins, involves separate mechanisms. This interaction does not lead to macrophage lysis, however, and one or more of these eosinophil proteins might directly affect macrophage function.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8434356      PMCID: PMC464245          DOI: 10.1136/thx.48.1.57

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  28 in total

1.  Activated eosinophils in coeliac disease.

Authors:  J F Colombel; A Janin; G Torpier
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

Review 2.  The eosinophilic pneumonias.

Authors:  A A Liebow; C B Carrington
Journal:  Medicine (Baltimore)       Date:  1969-07       Impact factor: 1.889

3.  Structural homology of tropomyosins from the human trematode Schistosoma mansoni and its intermediate host Biomphalaria glabrata.

Authors:  C Dissous; G Torpier; O Duvaux-Miret; A Capron
Journal:  Mol Biochem Parasitol       Date:  1990-12       Impact factor: 1.759

4.  Noncytotoxic activation of neutrophils by eosinophil granule major basic protein. Effect on superoxide anion generation and lysosomal enzyme release.

Authors:  J N Moy; G J Gleich; L L Thomas
Journal:  J Immunol       Date:  1990-10-15       Impact factor: 5.422

5.  Chronic eosinophilic pneumonia (Carrington's): a follow-up study.

Authors:  D L Pearson; E C Rosenow
Journal:  Mayo Clin Proc       Date:  1978-02       Impact factor: 7.616

6.  Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro.

Authors:  S Motojima; E Frigas; D A Loegering; G J Gleich
Journal:  Am Rev Respir Dis       Date:  1989-03

7.  Mature eosinophils stimulated to develop in human cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. Part I. Piecemeal degranulation of specific granules and distribution of Charcot-Leyden crystal protein.

Authors:  A M Dvorak; T Furitsu; L Letourneau; T Ishizaka; S J Ackerman
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

8.  Release of granule proteins by eosinophils from allergic and nonallergic patients with eosinophilia on immunoglobulin-dependent activation.

Authors:  M Tomassini; A Tsicopoulos; P C Tai; V Gruart; A B Tonnel; L Prin; A Capron; M Capron
Journal:  J Allergy Clin Immunol       Date:  1991-09       Impact factor: 10.793

9.  Chronic eosinophilic pneumonia. Ultrastructural evidence of marked immunoglobulin production plus macrophagic ingestion of eosinophils and eosinophilic lysosomes leading to intracytoplasmic Charcot-Leyden crystals.

Authors:  R E Kanner; S P Hammar
Journal:  Chest       Date:  1977-01       Impact factor: 9.410

10.  Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein.

Authors:  G Torpier; J F Colombel; C Mathieu-Chandelier; M Capron; J P Dessaint; A Cortot; J C Paris; A Capron
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

View more
  5 in total

1.  MR findings in patients with disabling musculocutaneous chronic graft-versus-host disease.

Authors:  M Horger; A Boss; W Bethge; C Faul; G Fierlbeck; A Bornemann; C D Claussen; W Vogel
Journal:  Skeletal Radiol       Date:  2008-07-12       Impact factor: 2.199

Review 2.  "Ultimate activation" of eosinophils in vivo: lysis and release of clusters of free eosinophil granules (Cfegs).

Authors:  C G Persson; J S Erjefält
Journal:  Thorax       Date:  1997-06       Impact factor: 9.139

3.  Essential Role of Enzymatic Activity in the Leishmanicidal Mechanism of the Eosinophil Cationic Protein (RNase 3).

Authors:  María Ángeles Abengózar; María Fernández-Reyes; Vivian A Salazar; Marc Torrent; Beatriz G de la Torre; David Andreu; Ester Boix; Luis Rivas
Journal:  ACS Infect Dis       Date:  2022-06-22       Impact factor: 5.578

Review 4.  Eosinophilic pneumonias.

Authors:  Praveen Akuthota; Peter F Weller
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

5.  Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease.

Authors:  S Dubucquoi; A Janin; O Klein; P Desreumaux; P Quandalle; A Cortot; M Capron; J F Colombel
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.